ClinicalTrials.gg
RecruitingNCT07275879Updated Dec 10, 2025

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

An interventional study of Ureteric stent insertion in Ureteral Double-J Stent, Urolithiasis and Quality of Life, sponsored by St. Luke's Clinical Hospital, Russia. Recruiting at 1 site in Russia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-10.

Sponsored by St. Luke's Clinical Hospital, Russia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS).

SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life.

Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.

Read the detailed description

Study Design:

Prospective, randomized, open-label, controlled trial with two parallel arms.

Study Center:

Department of Urology, St. Luke's Clinical Hospital, St. Petersburg, Russia

Study Population:

All patients should not be prestented and should have no ureteral obstruction. 40 patients, divided into four equal groups of 20 people each:

Group I (standard DJ stent):

Group II (modified DJ stent)

Procedure for evaluation:

After surgery ( RIRS, ureteroscopy) reflux is assessed (gravity-filling cystogram). After stenting, the presence of post-stent reflux is assessed.

In the postoperative period, patients complete the USSQ (1st day, 7th day and before stent removal).

Statistics method:

The results are presented as the median and interquartile range (IQR) for continuous variables, and as frequencies (n with percentage %) for categorical variables. Statistical comparisons of all primary and secondary outcome measures between different treatment groups were conducted using the Mann-Whitney U test for continuous data. Meanwhile, categorical variables were analyzed using either Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Thenthreshold for statistical significance was established at 5%, implying that a p-value less than 0.05 (p \< 0.05) was considered statistically significant for all tests performed.

02

Conditions studied

  • Ureteral Double-J Stent
  • Urolithiasis
  • Quality of Life

Browse trials for

03

In context

Urolithiasis

253 studies on the registry are indexed under Urolithiasis; 67 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 182 interventional studies indexed under Urolithiasis.

Browse Urolithiasis studies →

Lead sponsor

St. Luke's Clinical Hospital, Russia is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years and older
  • Patients with kidney stones
  • Patients with ureteral stones

Exclusion criteria

Exclusion Criteria:

  • Congenital anomalies of the urinary tract
  • Urinary tract infections
  • Upper urinary tract obstruction
  • Complicated ureteroscopy (e.g., ureteral perforation)
  • Pregnancy
  • Pre-stented patients
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Group I (DJ stent)

    Non-prestented patients who will insert a standard DJ stent after surgery

    Procedure: Ureteric stent insertion

  • Experimental
    Group II (modified DJ stent)

    Non-prestented patients who will insert a modified DJ stent after surgery

    Procedure: Ureteric stent insertion

Interventions

  • ProcedureUreteric stent insertion

    Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting

06

What researchers measure

Primary outcomes

  1. ureteral reflux

    Injection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.

    Time frame: Intraoperative

  2. Assessment the Ureteral Stent Symptom Questionnaire (USSQ)

    Ureteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents. USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains: Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.

    Time frame: Postoperative: 1st and 7th day, before stent removal

Secondary outcomes

  1. Patient's height

    The patient's height is measured in centimeters.

    Time frame: Preoperative

  2. Patient's weight

    The patient's weight is measured in centimeters.

    Time frame: Preoperative

  3. Body mass index (BMI)

    Body mass index (BMI) is a value derived from the mass (weight) and height of a person. BMI = kg/m2

    Time frame: Preoperative

  4. Operative time

    total operative time in minutes

    Time frame: Intraoperative (measured from start to end of procedure)

  5. Surgery

    Type of surgery: ureteroscopy or retrograde intrarenal surgery or stenting

    Time frame: Preoperative

07

Study locations

1 of 1 sites recruiting
  • St. Luke's Clinical Hospital
    Saint Petersburg, Outside U.S./Canada, Russia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — We are currently finalizing our data sharing policy. All required individual participant data underlying the reported results will be made available for regulatory purposes immediately upon request, and may be shared with researchers following publication after de-identification, contingent on submission of a methodologically sound proposal and compliance with institutional and national privacy regulations

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07275879
Lead sponsor
St. Luke's Clinical Hospital, Russia
Responsible party
Mikheev Yury (Urologist, St. Luke's Clinical Hospital, Russia) — Principal investigator
First posted
Dec 10, 2025
Start date
Dec 28, 2025 (estimated)
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Dec 10, 2025

Study contacts

Dmitriy Sytnik
Contact
doc.dmitriysytnik@gmail.com
+7 931 367 78 58
Yury Mikheev
Contact
mikheevyra@gmail.com
+79315412190

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion